Lv4
436 积分 2022-03-25 加入
Efficacy and safety of tislelizumab combined with chemotherapy for locally advanced penile cancer: a prospective, single-arm clinical study
2个月前
已关闭
Efficacy and Safety of Checkpoint Inhibitors Combined with Bacillus Calmette-Guérin (BCG) in BCG-naïve High-risk Non–muscle-invasive Bladder Cancer: Synthesis of Evidence from the ALBAN, CREST, and POTOMAC Trials
2个月前
已完结
Understanding patient perspectives in the management of their muscle‐invasive bladder cancer
3个月前
已完结
First Results of NURE-Combo: A Phase II Study of Neoadjuvant Nivolumab and Nab-Paclitaxel, Followed by Postsurgical Adjuvant Nivolumab, for Muscle-Invasive Bladder Cancer
4个月前
已完结
Effects of Bisphosphonates and Denosumab on Dental Implants: A Systematic Review With Meta‐Analysis
4个月前
已完结
Urinary Tumor DNA MRD Analysis to Identify Responders to Neoadjuvant Immunotherapy in Muscle-invasive Bladder Cancer
7个月前
已完结
Significance of ERBB2 Overexpression in Therapeutic Resistance and Cancer-Specific Survival in Muscle-Invasive Bladder Cancer Patients Treated With Chemoradiation-Based Selective Bladder-Sparing Approach
8个月前
已关闭
The evolving panorama of HER2-targeted treatments in metastatic urothelial cancer: A systematic review and future perspectives
8个月前
已完结
Disitamab vedotin plus toripalimab in patients with locally advanced or metastatic urothelial carcinoma (RC48-C014): a phase 1b/2 dose-escalation and dose-expansion study
8个月前
已完结
皖公网安备34019202002308
